TY - CONF T1 - PROGRESSIVE AND SUSTAINED DISEASE CONTROL IN PATIENTS WITH ATOPIC DERMATITIS (AD) AGED 12-17 YEARS TREATED WITH TRALOKINUMAB FOR 52 WEEKS JO - ACTA DERMATO-VENEREOLOGICA PY - 2023/01/01 AU - Wollenberg A AU - Cork MJ AU - Hong HC-H AU - Taveira CM AU - Kurbasic A AU - Vacko E AU - Paller AS ED - VL - 103 SP - 30 EP - 30 Y2 - 2025/05/29 ER -